The Access to Infertility Treatment and Care Act (HR 2803 / S 1461, 116th Congress) seeks to expand healthcare coverage of infertility treatments, including assisted reproductive technology procedures (e.g., in vitro fertilization) and standard fertility preservation services (e.g., embryo or oocyte cryopreservation), in some contexts. The Act specifies that healthcare coverage for infertility would include various procedures including ovulation induction, egg retrieval, sperm retrieval, artificial insemination, in vitro fertilization, genetic screening, and intracytoplasmic sperm injection, among other procedures which might be medically necessary. The Act specifically mentions that the American Society for Reproductive Medicine, RESOLVE: The National Infertility Association, and the American College of Obstetricians and Gynecologists would consult with the federal government in determining when these treatments are medically appropriate.
There are additional patient protections built into the Act, including that health insurers cannot provide incentives to discourage participants from using such services, cannot prohibit healthcare providers from discussing such treatments with patients, and cannot penalize reimbursements from a healthcare provider for providing these services.
Infertility can result from a number of factors, but some estimate that 50% of cases of infertility can be linked to a genetic defect. Additionally, many treatments for infertility – including in vitro fertilization – use genetic techniques to produce a viable fetus.